Considering that HK-2 overexpression is observed in most hepatocellular carcinoma tissues, these results suggest that chrysin or its analogs could be effective drugs in treating hepatocellular carcinoma [124]. This evidence concerns the gene HK2 and hepatocellular carcinoma.